On the other hand, the decrease in serum glucose and AUCvalues in the Diabetes + Api3 group compared to the diabetes groupindicates that the effects of Apilarnil on type 2 diabetes might bemediated through different pathways. This evidence concerns the gene XIAP and diabetes mellitus.